These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 23095326)

  • 1. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
    Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
    Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder.
    Jarčušková D; Tkáč I; Hlaváčová N; Yaluri AS; Kozárová M; Habalová V; Klimčáková L; Židzik J; Javorský M; Bednářová A
    BMC Psychiatry; 2024 Oct; 24(1):690. PubMed ID: 39407134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
    Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
    Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population.
    Mandal T; Bairy LK; Sharma PSVN
    Eur J Clin Pharmacol; 2020 Jun; 76(6):807-814. PubMed ID: 32253447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
    Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
    Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
    Manoharan A; Shewade DG; Rajkumar RP; Adithan S
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
    Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
    J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
    Ng C; Sarris J; Singh A; Bousman C; Byron K; Peh LH; Smith DJ; Tan CH; Schweitzer I
    Hum Psychopharmacol; 2013 Sep; 28(5):516-22. PubMed ID: 24014145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderation of antidepressant response by the serotonin transporter gene.
    Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
    Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism.
    Bousman CA; Sarris J; Won ES; Chang HS; Singh A; Lee HY; Ham BJ; Tan CH; Lee MS; Ng CH
    J Clin Psychopharmacol; 2014 Oct; 34(5):645-8. PubMed ID: 24943391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
    Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lahti J; Alho H; Lönnqvist J; Haukka J; Saarikoski ST
    Psychiatry Res; 2011 Mar; 186(1):53-7. PubMed ID: 20800901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
    Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
    J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.
    Tomita T; Yasui-Furukori N; Nakagami T; Tsuchimine S; Ishioka M; Kaneda A; Sugawara N; Kaneko S
    PLoS One; 2014; 9(5):e98099. PubMed ID: 24858363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.
    Kronenberg S; Apter A; Brent D; Schirman S; Melhem N; Pick N; Gothelf D; Carmel M; Frisch A; Weizman A
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):741-50. PubMed ID: 18315446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
    Illi A; Poutanen O; Setälä-Soikkeli E; Kampman O; Viikki M; Huhtala H; Mononen N; Haraldsson S; Koivisto PA; Leinonen E; Lehtimäki T
    Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):95-102. PubMed ID: 20640435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
    Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
    Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERT and NET polymorphisms, temperament and antidepressant response.
    Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
    Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporter genotype and function in relation to antidepressant response in Koreans.
    Myung W; Lim SW; Kim S; Kim H; Chung JW; Seo MY; Kim JW; Carroll BJ; Kim DK
    Psychopharmacology (Berl); 2013 Jan; 225(2):283-90. PubMed ID: 22885912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.